speb/financial-data huggingface dataset:
IMXI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -5530000.00
IMXI cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1209000.00
IMXI income_statement (annual, 2025-12-31) — Basic Average Shares: 29938268.00
IMXI income_statement (annual, 2025-12-31) — Basic EPS: 1.09
IMXI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 130503000.00
IMXI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 151589000.00
IMXI balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 103000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 103000.00
IMXI cash_flow (annual, 2025-12-31) — Capital Expenditure: -21074000.00
IMXI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4361000.00
IMXI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 21690000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 21690000.00
IMXI balance_sheet (annual, 2025-12-31) — Capital Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4000.00
IMXI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 168682000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 168682000.00
IMXI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 168682000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 168682000.00
IMXI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 20795000.00
IMXI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 36933000.00
IMXI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -22066000.00
IMXI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4561000.00
IMXI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 36887000.00
IMXI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -15622000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Account Payable: -17827000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -8931000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -7902000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1841000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Payable: -17791000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Payable: -15360000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -17791000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -15360000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -16592000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -39782000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Receivables: -7053000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 11919000.00
IMXI cash_flow (annual, 2025-12-31) — Change In Working Capital: -49338000.00
IMXI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -45064000.00
IMXI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -7053000.00
IMXI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 11919000.00
IMXI cash_flow (annual, 2025-12-31) — Changes In Cash: 35616000.00
IMXI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 16750000.00
IMXI balance_sheet (annual, 2025-12-31) — Common Stock: 4000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Common Stock: 4000.00
IMXI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 161054000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 161054000.00
IMXI cash_flow (annual, 2025-12-31) — Common Stock Payments: -16334000.00
IMXI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
IMXI income_statement (annual, 2025-12-31) — Cost Of Revenue: 388866000.00
IMXI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 94185000.00
IMXI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 13422000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 13422000.00
IMXI balance_sheet (annual, 2025-12-31) — Current Assets: 353159000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Assets: 353159000.00
IMXI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 6207000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 6207000.00
IMXI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6207000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6207000.00
IMXI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
IMXI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
IMXI balance_sheet (annual, 2025-12-31) — Current Liabilities: 140957000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 140957000.00
IMXI cash_flow (annual, 2025-12-31) — Deferred Income Tax: 5199000.00
IMXI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 4831000.00
IMXI cash_flow (annual, 2025-12-31) — Deferred Tax: 5199000.00
IMXI cash_flow (quarterly, 2025-12-31) — Deferred Tax: 4831000.00
IMXI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 17161000.00
IMXI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4668000.00
IMXI income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 17161000.00
IMXI income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4668000.00
IMXI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 17161000.00
IMXI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 4668000.00
IMXI income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 17161000.00
IMXI income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 4668000.00
IMXI income_statement (annual, 2025-12-31) — Diluted Average Shares: 30181194.00
IMXI income_statement (annual, 2025-12-31) — Diluted EPS: 1.08
IMXI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 8932000.00
IMXI income_statement (annual, 2025-12-31) — EBIT: 58936000.00
IMXI income_statement (quarterly, 2025-12-31) — EBIT: 14865000.00
IMXI income_statement (annual, 2025-12-31) — EBITDA: 76097000.00
IMXI income_statement (quarterly, 2025-12-31) — EBITDA: 19533000.00
IMXI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2563000.00
IMXI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 343000.00
IMXI cash_flow (annual, 2025-12-31) — End Cash Position: 168682000.00
IMXI cash_flow (quarterly, 2025-12-31) — End Cash Position: 168682000.00
IMXI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 20795000.00
IMXI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 36933000.00
IMXI cash_flow (annual, 2025-12-31) — Free Cash Flow: 15813000.00
IMXI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -19983000.00
IMXI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 1464000.00
IMXI cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 353000.00
IMXI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 104000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 104000.00
IMXI income_statement (annual, 2025-12-31) — General And Administrative Expense: 125768000.00
IMXI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 31779000.00
IMXI balance_sheet (annual, 2025-12-31) — Goodwill: 53986000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Goodwill: 53986000.00
IMXI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 79390000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 79390000.00
IMXI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 110899000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 110899000.00
IMXI balance_sheet (annual, 2025-12-31) — Gross PPE: 136740000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 136740000.00
IMXI income_statement (annual, 2025-12-31) — Gross Profit: 218910000.00
IMXI income_statement (quarterly, 2025-12-31) — Gross Profit: 53227000.00
IMXI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 1209000.00
IMXI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 17889000.00
IMXI cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1183000.00
IMXI income_statement (annual, 2025-12-31) — Interest Expense: 11836000.00
IMXI income_statement (quarterly, 2025-12-31) — Interest Expense: 3062000.00
IMXI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 11836000.00
IMXI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3062000.00
IMXI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 10809000.00
IMXI cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2805000.00
IMXI balance_sheet (annual, 2025-12-31) — Invested Capital: 355879000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 355879000.00
IMXI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -22066000.00
IMXI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4561000.00
IMXI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 8084500000.00
IMXI cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1997900000.00
IMXI balance_sheet (annual, 2025-12-31) — Land And Improvements: 0.00
IMXI balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 0.00
IMXI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 15483000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 15483000.00
IMXI balance_sheet (annual, 2025-12-31) — Long Term Debt: 194825000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 194825000.00
IMXI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 210308000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 210308000.00
IMXI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 8084500000.00
IMXI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -8046286000.00
IMXI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -8046286000.00
IMXI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 103859000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 103859000.00
IMXI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1399000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -200000.00
IMXI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -16334000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IMXI balance_sheet (annual, 2025-12-31) — Net Debt: 26143000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Net Debt: 26143000.00
IMXI income_statement (annual, 2025-12-31) — Net Income: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 8932000.00
IMXI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 32671000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 32671000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 8932000.00
IMXI income_statement (annual, 2025-12-31) — Net Interest Income: -11836000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Interest Income: -3062000.00
IMXI cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 407000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: 0.00
IMXI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 38214000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 36900000.00
IMXI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 38214000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 38214000.00
IMXI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -11836000.00
IMXI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3062000.00
IMXI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1131000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -23000.00
IMXI balance_sheet (annual, 2025-12-31) — Net PPE: 73027000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Net PPE: 73027000.00
IMXI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -21074000.00
IMXI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -4361000.00
IMXI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 81664000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 81664000.00
IMXI balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 2696000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 2696000.00
IMXI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 5372000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5372000.00
IMXI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5372000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5372000.00
IMXI balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 1750000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 1750000.00
IMXI income_statement (annual, 2025-12-31) — Normalized EBITDA: 88512000.00
IMXI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 22896000.00
IMXI income_statement (annual, 2025-12-31) — Normalized Income: 41287010.00
IMXI income_statement (quarterly, 2025-12-31) — Normalized Income: 11476972.97
IMXI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 36887000.00
IMXI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -15622000.00
IMXI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1464000.00
IMXI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 353000.00
IMXI income_statement (annual, 2025-12-31) — Operating Income: 68065000.00
IMXI income_statement (quarterly, 2025-12-31) — Operating Income: 14942000.00
IMXI income_statement (annual, 2025-12-31) — Operating Revenue: 589315000.00
IMXI income_statement (quarterly, 2025-12-31) — Operating Revenue: 142243000.00
IMXI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29719115.00
IMXI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 29719115.00
IMXI balance_sheet (annual, 2025-12-31) — Other Current Assets: 1806000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1806000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 150000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 150000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 104000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 104000.00
IMXI income_statement (annual, 2025-12-31) — Other Gand A: 50732000.00
IMXI income_statement (quarterly, 2025-12-31) — Other Gand A: 13257000.00
IMXI income_statement (annual, 2025-12-31) — Other Income Expense: -9129000.00
IMXI income_statement (quarterly, 2025-12-31) — Other Income Expense: -77000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 25404000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 25404000.00
IMXI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 11329000.00
IMXI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5339000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 7669000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 7669000.00
IMXI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3286000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Payable: 103921000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Payable: 103921000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Properties: 32778000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Properties: 32778000.00
IMXI balance_sheet (annual, 2025-12-31) — Other Receivables: 1798000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1798000.00
IMXI balance_sheet (annual, 2025-12-31) — Payables: 121178000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Payables: 121178000.00
IMXI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 134600000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 134600000.00
IMXI balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
IMXI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IMXI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 75504000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 75504000.00
IMXI income_statement (annual, 2025-12-31) — Pretax Income: 47100000.00
IMXI income_statement (quarterly, 2025-12-31) — Pretax Income: 11803000.00
IMXI cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 46000.00
IMXI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 56000.00
IMXI balance_sheet (annual, 2025-12-31) — Properties: 0.00
IMXI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IMXI income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 7916000.00
IMXI income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 1838000.00
IMXI cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 7916000.00
IMXI cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 1838000.00
IMXI cash_flow (annual, 2025-12-31) — Purchase Of Business: -1399000.00
IMXI cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -200000.00
IMXI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -21074000.00
IMXI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -4361000.00
IMXI balance_sheet (annual, 2025-12-31) — Receivables: 107167000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Receivables: 107167000.00
IMXI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 388866000.00
IMXI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 94185000.00
IMXI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 17161000.00
IMXI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4668000.00
IMXI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -8046286000.00
IMXI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1961000000.00
IMXI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -16334000.00
IMXI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
IMXI income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 11206000.00
IMXI income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 2154000.00
IMXI balance_sheet (annual, 2025-12-31) — Retained Earnings: 290141000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 290141000.00
IMXI income_statement (annual, 2025-12-31) — Salaries And Wages: 75036000.00
IMXI income_statement (quarterly, 2025-12-31) — Salaries And Wages: 18522000.00
IMXI cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 407000.00
IMXI cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 0.00
IMXI income_statement (annual, 2025-12-31) — Selling General And Administration: 125768000.00
IMXI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 31779000.00
IMXI balance_sheet (annual, 2025-12-31) — Share Issued: 40682683.00
IMXI balance_sheet (quarterly, 2025-12-31) — Share Issued: 40682683.00
IMXI income_statement (annual, 2025-12-31) — Special Income Charges: -12415000.00
IMXI income_statement (quarterly, 2025-12-31) — Special Income Charges: -3363000.00
IMXI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 9276000.00
IMXI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2272000.00
IMXI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 161054000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 161054000.00
IMXI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 81664000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 81664000.00
IMXI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3798990.00
IMXI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -818027.03
IMXI income_statement (annual, 2025-12-31) — Tax Provision: 14429000.00
IMXI income_statement (quarterly, 2025-12-31) — Tax Provision: 2871000.00
IMXI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.31
IMXI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
IMXI balance_sheet (annual, 2025-12-31) — Total Assets: 517691000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Assets: 517691000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Capitalization: 355879000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 355879000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Debt: 216515000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Debt: 216515000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 161054000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 161054000.00
IMXI income_statement (annual, 2025-12-31) — Total Expenses: 539711000.00
IMXI income_statement (quarterly, 2025-12-31) — Total Expenses: 132470000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 356637000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 356637000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 164532000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 164532000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 215680000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 215680000.00
IMXI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 55650000.00
IMXI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 11579000.00
IMXI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1940000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1940000.00
IMXI income_statement (annual, 2025-12-31) — Total Unusual Items: -12415000.00
IMXI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3363000.00
IMXI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -12415000.00
IMXI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3363000.00
IMXI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 10963568.00
IMXI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 10963568.00
IMXI balance_sheet (annual, 2025-12-31) — Treasury Stock: 217030000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 217030000.00
IMXI balance_sheet (annual, 2025-12-31) — Working Capital: 212202000.00
IMXI balance_sheet (quarterly, 2025-12-31) — Working Capital: 212202000.00
IMXI income_statement (quarterly, 2026-03-31) — +Operating Expense: 38021000.00
IMXI income_statement (quarterly, 2026-03-31) — +Total Revenue: 121952000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15380000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 106278000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -14600000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 89433000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -4837000.00
IMXI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29858890.00
IMXI income_statement (quarterly, 2026-03-31) — Basic EPS: 0.02
IMXI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 168682000.00
IMXI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5493000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 21468000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 170324000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 170324000.00
IMXI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 45061000.00
IMXI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5493000.00
IMXI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -37364000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 4700000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1787000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Payable: 1310000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1310000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -45944000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -3862000.00
IMXI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -50283000.00
IMXI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -3862000.00
IMXI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2204000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 162692000.00
IMXI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
IMXI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 79091000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 11481000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Current Assets: 402372000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6109000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6109000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 141834000.00
IMXI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -129000.00
IMXI cash_flow (quarterly, 2026-03-31) — Deferred Tax: -129000.00
IMXI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 4685000.00
IMXI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 4685000.00
IMXI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 4685000.00
IMXI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 4685000.00
IMXI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 30382817.00
IMXI income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.02
IMXI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — EBIT: 3674000.00
IMXI income_statement (quarterly, 2026-03-31) — EBITDA: 8359000.00
IMXI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -562000.00
IMXI cash_flow (quarterly, 2026-03-31) — End Cash Position: 170324000.00
IMXI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 45061000.00
IMXI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -42857000.00
IMXI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 383000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -367000.00
IMXI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 30445000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Goodwill: 53986000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 78358000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 111115000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 88857000.00
IMXI income_statement (quarterly, 2026-03-31) — Gross Profit: 42861000.00
IMXI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 965000.00
IMXI income_statement (quarterly, 2026-03-31) — Interest Expense: 2208000.00
IMXI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2208000.00
IMXI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1942000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 403506000.00
IMXI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5493000.00
IMXI cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1961500000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 15359000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 240814000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 256173000.00
IMXI cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1961500000.00
IMXI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1915500000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
IMXI balance_sheet (quarterly, 2026-03-31) — Net Debt: 70490000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 511000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 511000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 511000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
IMXI income_statement (quarterly, 2026-03-31) — Net Interest Income: -2208000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 46000000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 46000000.00
IMXI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2208000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -11000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Net PPE: 74257000.00
IMXI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -5493000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 84334000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 2784000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 5243000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 5243000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 1385000.00
IMXI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 9525000.00
IMXI income_statement (quarterly, 2026-03-31) — Normalized Income: 1210600.00
IMXI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -37364000.00
IMXI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 383000.00
IMXI income_statement (quarterly, 2026-03-31) — Operating Income: 4840000.00
IMXI income_statement (quarterly, 2026-03-31) — Operating Revenue: 116072000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 30115259.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2124000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 150000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -367000.00
IMXI income_statement (quarterly, 2026-03-31) — Other Gand A: 11555000.00
IMXI income_statement (quarterly, 2026-03-31) — Other Income Expense: -1166000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 24372000.00
IMXI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2052000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6786000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Payable: 99239000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Properties: 88857000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1796000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Payables: 124094000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 135575000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IMXI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 121850000.00
IMXI income_statement (quarterly, 2026-03-31) — Pretax Income: 1466000.00
IMXI cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -928000.00
IMXI income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 2891000.00
IMXI cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 2891000.00
IMXI cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
IMXI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -5493000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Receivables: 108074000.00
IMXI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 79091000.00
IMXI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 4685000.00
IMXI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1915500000.00
IMXI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
IMXI income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 1166000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 290652000.00
IMXI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 18890000.00
IMXI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 30445000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Share Issued: 41078827.00
IMXI income_statement (quarterly, 2026-03-31) — Special Income Charges: -1166000.00
IMXI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2526000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 162692000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 84334000.00
IMXI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -466400.00
IMXI income_statement (quarterly, 2026-03-31) — Tax Provision: 955000.00
IMXI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
IMXI balance_sheet (quarterly, 2026-03-31) — Total Assets: 565942000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 403506000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Debt: 262282000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 162692000.00
IMXI income_statement (quarterly, 2026-03-31) — Total Expenses: 117112000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 403250000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 163570000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 261416000.00
IMXI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 3674000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 9475000.00
IMXI income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1166000.00
IMXI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1166000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 10963568.00
IMXI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 217030000.00
IMXI balance_sheet (quarterly, 2026-03-31) — Working Capital: 260538000.00
IN.V cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 451870.00
IN.V income_statement (annual, 2021-12-31) — Basic Average Shares: 17175488.00
IN.V income_statement (annual, 2021-12-31) — Basic EPS: -0.16
IN.V income_statement (annual, 2021-12-31) — Diluted Average Shares: 17175488.00
IN.V income_statement (annual, 2021-12-31) — Diluted EPS: -0.16
IN.V income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 451870.00
IN.V cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -76210.00
IN.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -360182.00
IN.V cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -61903.00
IN.V balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 61903.00
IN.V balance_sheet (annual, 2021-12-31) — Other Equity Interest: 11250.00
IN.V cash_flow (annual, 2021-12-31) — Other Non Cash Items: 1176634.00
IN.V cash_flow (annual, 2021-12-31) — Purchase Of Business: -79640.00
IN.V cash_flow (annual, 2021-12-31) — Purchase Of PPE: -2022955.00
IN.V income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 1176674.00
IN.V cash_flow (annual, 2021-12-31) — Sale Of Business: 3430.00
IN.V income_statement (annual, 2021-12-31) — Special Income Charges: -1628544.00
IN.V income_statement (annual, 2022-12-31) — +Operating Expense: 640450.00
IN.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 45939.00
IN.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 1772885.00
IN.V income_statement (annual, 2022-12-31) — Basic Average Shares: 24303985.00
IN.V income_statement (annual, 2022-12-31) — Basic EPS: -0.10
IN.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1895329.00
IN.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -698445.00
IN.V balance_sheet (annual, 2022-12-31) — Capital Stock: 6364272.00
IN.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 663998.00
IN.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 663998.00
IN.V balance_sheet (annual, 2022-12-31) — Cash Financial: 663998.00
IN.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
IN.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -691302.00
IN.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -540029.00
IN.V cash_flow (annual, 2022-12-31) — Change In Account Payable: -155364.00
IN.V cash_flow (annual, 2022-12-31) — Change In Payable: -155744.00
IN.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -155744.00
IN.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 10050.00
IN.V cash_flow (annual, 2022-12-31) — Change In Receivables: -14010.00
IN.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -159704.00
IN.V cash_flow (annual, 2022-12-31) — Changes In Cash: -1231331.00
IN.V balance_sheet (annual, 2022-12-31) — Common Stock: 6364272.00
IN.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2075596.00
IN.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Current Assets: 753623.00
IN.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 48861.00
IN.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 24303985.00
IN.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.10
IN.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2411115.00
IN.V balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 2922.00
IN.V income_statement (annual, 2022-12-31) — EBIT: -640450.00
IN.V income_statement (annual, 2022-12-31) — EBITDA: -640450.00
IN.V cash_flow (annual, 2022-12-31) — End Cash Position: 663998.00
IN.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
IN.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -1238474.00
IN.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 2220.00
IN.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1103002.00
IN.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 611869.00
IN.V income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1772885.00
IN.V cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
IN.V cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Invested Capital: 2075596.00
IN.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -691302.00
IN.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
IN.V cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
IN.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
IN.V income_statement (annual, 2022-12-31) — Net Income: -2411115.00
IN.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2411115.00
IN.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2411115.00
IN.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2411115.00
IN.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2411115.00
IN.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2411115.00
IN.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2411115.00
IN.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 7143.00
IN.V balance_sheet (annual, 2022-12-31) — Net PPE: 1316074.00
IN.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -698445.00
IN.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2075596.00
IN.V income_statement (annual, 2022-12-31) — Normalized EBITDA: 1130215.00
IN.V income_statement (annual, 2022-12-31) — Normalized Income: -640450.00
IN.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -540029.00
IN.V income_statement (annual, 2022-12-31) — Operating Income: -640450.00
IN.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 24391365.00
IN.V income_statement (annual, 2022-12-31) — Other Gand A: 353964.00
IN.V income_statement (annual, 2022-12-31) — Other Income Expense: -1770665.00
IN.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 54760.00
IN.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 28581.00
IN.V balance_sheet (annual, 2022-12-31) — Payables: 48861.00
IN.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 48861.00
IN.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 10085.00
IN.V income_statement (annual, 2022-12-31) — Pretax Income: -2411115.00
IN.V cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
IN.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -698445.00
IN.V balance_sheet (annual, 2022-12-31) — Receivables: 79540.00
IN.V income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -5391678.00
IN.V income_statement (annual, 2022-12-31) — Salaries And Wages: 257905.00
IN.V cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
IN.V income_statement (annual, 2022-12-31) — Selling General And Administration: 611869.00
IN.V balance_sheet (annual, 2022-12-31) — Share Issued: 24391365.00
IN.V income_statement (annual, 2022-12-31) — Special Income Charges: -1772885.00
IN.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 257905.00
IN.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2075596.00
IN.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2075596.00
IN.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IN.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
IN.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 79540.00
IN.V balance_sheet (annual, 2022-12-31) — Total Assets: 2124457.00
IN.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 2075596.00
IN.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2075596.00
IN.V income_statement (annual, 2022-12-31) — Total Expenses: 640450.00
IN.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 48861.00
IN.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1370834.00
IN.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IN.V income_statement (annual, 2022-12-31) — Total Unusual Items: -1770665.00
IN.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1770665.00
IN.V balance_sheet (annual, 2022-12-31) — Working Capital: 704762.00
IN.V income_statement (annual, 2023-12-31) — +Operating Expense: 281696.00
IN.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
IN.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 60498.00
IN.V cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
IN.V income_statement (annual, 2023-12-31) — Basic Average Shares: 24391367.00
IN.V income_statement (annual, 2023-12-31) — Basic EPS: -0.01
IN.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 663998.00
IN.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -19750.00
IN.V balance_sheet (annual, 2023-12-31) — Capital Stock: 6364272.00
IN.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 560535.00
IN.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 560535.00
IN.V balance_sheet (annual, 2023-12-31) — Cash Financial: 560535.00
IN.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 0.00
IN.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 3905.00
IN.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -107368.00
IN.V cash_flow (annual, 2023-12-31) — Change In Account Payable: 14559.00
IN.V cash_flow (annual, 2023-12-31) — Change In Payable: 86112.00
IN.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 86112.00
IN.V cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2922.00
IN.V cash_flow (annual, 2023-12-31) — Change In Receivables: 53799.00
IN.V cash_flow (annual, 2023-12-31) — Change In Working Capital: 142833.00
IN.V cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 53799.00
IN.V cash_flow (annual, 2023-12-31) — Changes In Cash: -103463.00
IN.V balance_sheet (annual, 2023-12-31) — Common Stock: 6364272.00
IN.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1825395.00
IN.V cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
IN.V balance_sheet (annual, 2023-12-31) — Current Assets: 575685.00
IN.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 117219.00
IN.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 24391367.00
IN.V income_statement (annual, 2023-12-31) — Diluted EPS: -0.01
IN.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -277818.00
IN.V balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 56721.00
IN.V income_statement (annual, 2023-12-31) — EBIT: -281696.00
IN.V income_statement (annual, 2023-12-31) — EBITDA: -281696.00
IN.V cash_flow (annual, 2023-12-31) — End Cash Position: 560535.00
IN.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: 0.00
IN.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -127118.00